AU9137091A - Gaba and l-glutamic acid analogs for antiseizure treatment - Google Patents
Gaba and l-glutamic acid analogs for antiseizure treatmentInfo
- Publication number
- AU9137091A AU9137091A AU91370/91A AU9137091A AU9137091A AU 9137091 A AU9137091 A AU 9137091A AU 91370/91 A AU91370/91 A AU 91370/91A AU 9137091 A AU9137091 A AU 9137091A AU 9137091 A AU9137091 A AU 9137091A
- Authority
- AU
- Australia
- Prior art keywords
- gaba
- glutamic acid
- acid analogs
- antiseizure
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61869290A | 1990-11-27 | 1990-11-27 | |
US618692 | 1990-11-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU9137091A true AU9137091A (en) | 1992-06-25 |
Family
ID=24478754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU91370/91A Abandoned AU9137091A (en) | 1990-11-27 | 1991-11-20 | Gaba and l-glutamic acid analogs for antiseizure treatment |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU9137091A (es) |
MX (1) | MX9102241A (es) |
WO (1) | WO1992009560A1 (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU677008B2 (en) * | 1992-05-20 | 1997-04-10 | Northwestern University | Gaba and L-glutamic acid analogs for antiseizure treatment |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197819B1 (en) | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
US6001876A (en) | 1996-07-24 | 1999-12-14 | Warner-Lambert Company | Isobutylgaba and its derivatives for the treatment of pain |
US6153650A (en) * | 1996-10-23 | 2000-11-28 | Warner-Lambert Company | Substituted gamma aminobutyric acids as pharmaceutical agents |
WO1999008670A1 (en) | 1997-08-20 | 1999-02-25 | Guglietta, Antonio | Gaba analogs to prevent and treat gastrointestinal damage |
CU23028A3 (es) * | 1997-12-16 | 2005-02-23 | Warner Lambert Co | Aminas novedosas como agentes farmaceuticos. |
WO2000031020A1 (en) | 1998-11-25 | 2000-06-02 | Warner-Lambert Company | Improved gamma amino butyric acid analogs |
US6992109B1 (en) | 1999-04-08 | 2006-01-31 | Segal Catherine A | Method for the treatment of incontinence |
EP1171114B1 (en) * | 1999-04-08 | 2008-11-12 | Warner-Lambert Company LLC | Method for the treatment of incontinence |
EP1180058A1 (en) * | 1999-04-09 | 2002-02-20 | Warner-Lambert Company | Combinations of gaba analogs and tricyclic compounds to treat depression |
US6642398B2 (en) | 1999-06-10 | 2003-11-04 | Warner-Lambert Company | Mono-and disubstituted 3-propyl gamma-aminobutyric acids |
CN1310872C (zh) * | 1999-06-10 | 2007-04-18 | 沃尼尔·朗伯公司 | 单和双取代的3-丙基-γ-氨基丁酸 |
EP1840117A1 (en) * | 1999-06-10 | 2007-10-03 | Warner-Lambert Company LLC | Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
CA2356829A1 (en) * | 2000-09-22 | 2002-03-22 | Warner-Lambert Company | Method for treating asthma using pregabalin |
EP1343805A4 (en) | 2000-10-06 | 2005-07-20 | Xenoport Inc | COMPOUNDS DERIVED FROM GALLENIC ACIDS FOR THE PROVISION OF CONTINUING SYSTEMIC CONCENTRATIONS OF MEDICINAL PRODUCTS AFTER ORAL ADMINISTRATION |
WO2002032376A2 (en) | 2000-10-06 | 2002-04-25 | Xenoport, Inc. | Bile-acid conjugates for providing sustained systemic concentrations of drugs |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
ES2380287T3 (es) * | 2001-06-11 | 2012-05-10 | Xenoport, Inc. | Profármacos de análogos de GABA, composiciones y sus usos |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
EP1412324A4 (en) | 2001-06-11 | 2004-09-29 | Xenoport Inc | AMINO ACID CONJUGATES THAT RESULT IN GABA ANALOGA LASTING SYSTEMIC CONCENTRATIONS |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US6927036B2 (en) | 2002-02-19 | 2005-08-09 | Xero Port, Inc. | Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
WO2003080588A1 (en) | 2002-03-20 | 2003-10-02 | Xenoport | Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof |
WO2003099338A2 (en) | 2002-05-17 | 2003-12-04 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
WO2004052360A1 (en) | 2002-12-11 | 2004-06-24 | Xenoport, Inc. | Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof |
KR20060119971A (ko) | 2003-09-11 | 2006-11-24 | 제노포트 인코포레이티드 | Gaba 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방 |
CN1878546A (zh) * | 2003-09-12 | 2006-12-13 | 沃纳-兰伯特公司 | 治疗抑郁症和焦虑症的包括α-2δ配体和SSRI和/或SNRI的联用药物 |
MXPA06003043A (es) | 2003-09-17 | 2006-05-31 | Xenoport Inc | Tratamiento o prevencion del sindrome piernas inquietas utilizando prodrogas de analogos gaba. |
SG147437A1 (en) | 2003-10-14 | 2008-11-28 | Xenoport Inc | Crystalline form of gamma-aminobutyric acid analog |
PT1691811E (pt) | 2003-12-11 | 2014-10-30 | Sunovion Pharmaceuticals Inc | Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão |
RU2440112C2 (ru) | 2004-11-04 | 2012-01-20 | Ксенопорт, Инк. | Пероральная дозированная форма габапентина замедленного высвобождения |
EP1820502A1 (en) | 2006-02-10 | 2007-08-22 | Laboratorios Del Dr. Esteve, S.A. | Active substance combination comprising azolylcarbinol compounds |
WO2009094577A2 (en) | 2008-01-25 | 2009-07-30 | Xenoport, Inc. | Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use |
CA2706575C (en) | 2008-01-25 | 2015-07-14 | Xenoport, Inc. | Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs |
US7872046B2 (en) | 2008-01-25 | 2011-01-18 | Xenoport, Inc. | Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use |
EP2116539A1 (en) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof |
AU2009302241B2 (en) | 2008-10-08 | 2015-10-29 | Xgene Pharmaceutical Inc. | GABA conjugates and methods of use thereof |
US9192681B2 (en) | 2009-02-24 | 2015-11-24 | Nektar Therapeutics | Oligomer-amino acid conjugates |
EP2353591A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof |
EP2353598A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for use in the prevention and/or treatment of postoperative pain |
EP2388005A1 (en) | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
EP2415471A1 (en) | 2010-08-03 | 2012-02-08 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in opioid-induced hyperalgesia |
EP2524694A1 (en) | 2011-05-19 | 2012-11-21 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in diabetes type-2 associated pain |
GB201118481D0 (en) * | 2011-10-26 | 2011-12-07 | Givaudan Sa | Organic compounds |
ES2423254B1 (es) | 2012-02-15 | 2014-03-26 | Laboratec, S.L. | Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis |
US9066853B2 (en) | 2013-01-15 | 2015-06-30 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable fiber |
EP2948139B1 (en) | 2013-01-28 | 2019-06-12 | Lopez, Hector, L. | Methods of improving tolerability, pharmacodynamics, and efficacy of b-alanine and use therefor |
CN105873580B (zh) | 2013-12-17 | 2020-08-25 | 埃斯蒂维制药有限公司 | 加巴喷丁类化合物与σ受体配体的组合物 |
TW201607538A (zh) | 2013-12-17 | 2016-03-01 | 以斯提夫博士實驗室股份有限公司 | 血清素-去甲腎上腺素再攝取抑制劑(SNRIS)和σ受體配體組合物 |
AU2019271799B2 (en) | 2018-05-14 | 2023-10-12 | Xgene Pharmaceutical Inc. | Crystalline forms of 1-(acyloxy)-alkyl carbamate drug conjugates of naproxen and pregabalin |
DE202018105573U1 (de) | 2018-09-27 | 2018-10-19 | Laboratec | Pharmazeutische Zusammensetzung zur Behandlung der Harninkontinenz und Enuresis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2628980A (en) * | 1949-02-18 | 1953-02-17 | Gen Mills Inc | Beta-phenyl-gamma-nitroaldehydes |
JPS4940460B1 (es) * | 1971-08-28 | 1974-11-02 |
-
1991
- 1991-11-20 AU AU91370/91A patent/AU9137091A/en not_active Abandoned
- 1991-11-20 WO PCT/US1991/008701 patent/WO1992009560A1/en unknown
- 1991-11-27 MX MX9102241A patent/MX9102241A/es unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU677008B2 (en) * | 1992-05-20 | 1997-04-10 | Northwestern University | Gaba and L-glutamic acid analogs for antiseizure treatment |
Also Published As
Publication number | Publication date |
---|---|
WO1992009560A1 (en) | 1992-06-11 |
MX9102241A (es) | 1994-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU9137091A (en) | Gaba and l-glutamic acid analogs for antiseizure treatment | |
CA2255652A1 (en) | Isobutylgaba and its derivatives for the treatment of pain | |
AU5403290A (en) | Angiogenic butyric acid analogs and their prodrugs | |
AU7734391A (en) | Essential fatty acid treatment | |
AU1173195A (en) | Treatment of immunoregulatory disorders | |
EP0647134A4 (en) | METHODS AND COMPOSITIONS USED TO TREAT DEPRESSION AND OTHER CONDITIONS WITH OPTICALLY PURE SIBUTRAMINE (-). | |
AU659456B2 (en) | Fatty acid treatment | |
GB2274062B (en) | Tooth securement | |
EP0449405A3 (en) | Use of bisphosphonic acids for the treatment of calcium metabolism disorders | |
AU5216690A (en) | Periodontal disease treatment system | |
AU2649092A (en) | Desulphurisation treatment | |
EP0415510A3 (en) | L-glutamic acid derivatives | |
GB9303157D0 (en) | Treatment of a group of related disorders | |
AU3176595A (en) | Fatty acid treatment | |
GB9201920D0 (en) | Novel treatment i | |
EP0801645A4 (en) | WALLY COLORED POLYASPARTIGINIC ACID AND SALTS | |
AU649243B2 (en) | Edulcorant derived from L-aspartic or L-glutamic acid and its preparation process | |
AU7664291A (en) | Aminopolycarboxylic acid chelating agents | |
EP0469517A3 (en) | Process for producing l-glutamic acid | |
AU565635B2 (en) | L-glutamic acid oxidase | |
AU5419894A (en) | Dental treatment aid | |
AU2085692A (en) | Butyric acid amides | |
ZA931700B (en) | Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients | |
AU4529897A (en) | Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine | |
CS544987A1 (en) | 2,4-dioxy-4-(4-pentyloxyphenyl) butanoic acid's esters |